A randomized, controlled pilot study of MDMA (±3,4- Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD)

Journal of Psychopharmacology

Volumn 27, Issue 1, 2013, Pages 40-52

  Oehen, Peter ^a   Traber, Rafael ^b   Widmer, Verena ^a   Schnyder, Ulrich ^c  

^a Private Practice of Psychiatry and Psychotherapy   (Switzerland)

^b Psychiatric Hospital   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

entactogen; MDMA; MDMA assisted psychotherapy; Methylenedioxymethamphetamine; posttraumatic stress disorder; psychotherapy; PTSD

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ADULT; AGED; ANOREXIA; ANXIETY DISORDER; ARTICLE; BALANCE DISORDER; CLINICAL ARTICLE; CLINICIAN ADMINISTERED PTSD SCALE; COMMON COLD; CONCENTRATION LOSS; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; FATIGUE; FEMALE; FOLLOW UP; GAIT DISORDER; HUMAN; INSOMNIA; IRRITABILITY; JAW CLENCHING; JAW DISEASE; LEG DISEASE; LOW DRUG DOSE; MALE; MOOD; NAUSEA; NYSTAGMUS; PARESTHESIA; PILOT STUDY; POSTTRAUMATIC DIAGNOSTIC SCALE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RESTLESSNESS; SELF REPORT; SIDE EFFECT; SLEEP DISORDER; SWEATING; THIRST; WEAKNESS; XEROSTOMIA;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PILOT PROJECTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY; STRESS DISORDERS, POST-TRAUMATIC; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84871599190     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881112464827     Document Type: Article

References (53)

1. Bedi G, Luan Phan K, Angstadt M, et al. Effects of MDMA on sociability and neural response to social threat and social reward. Psychopharmacol. 2009 ; 207: 73-83
2. Benedek DM, Friedmann MJ, Zatzick D, et al. Guideline Watch (March 2009): Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder. Focus. 2009 ; 7: 204-213
3. Benzenhoefer UP, Passie T. The early history of ecstasy. Nervenarzt. 2006 ; 77: 95-96
4. Berkowitz RL, Coplan JD, Reddy DP, et al. The human dimension: How the prefrontal cortex modulates the subcortical fear response. Rev Neurosci. 2007 ; 18: 191-207
5. Bonny HL, Savary LM Music and Your Mind. Tarrytown, NY: Station Hill ; 1990 :
6. Bouso JC, Doblin R, Farré M, et al. J Psychoactive Drugs. 2008 ; 40: 225-236
7. Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: A randomized controlled trial. J Am Med Ass. 2000 ; 283: 1837-1844
8. Breslau N, Davis GC, Andreski P, et al. Traumatic events and posttraumatic stress disorder in an urban population of young adults. Arch Gen Psychiatry. 1991 ; 48: 216-222
9. Brunner E, Domhof S, Langer F Nonparametric Analysis of Longitudinal Data in Factorial Experiments. New York: Wiley and Sons ; 2002 :
10. Brunner E, Langer F Nichtparametrische Analyse Longitudinaler Daten (Non-Parametric Analysis of Longitudinal Data). Munich: R Oldenbourg Verlag ; 1999 :
11. Charuvastra A, Cloitre M. Social bonds and posttraumatic stress disorder. Ann Rev Psychol. 2008 ; 59: 301-328
12. Cloitre M. Effective psychotherapies for posttraumatic stress disorder: A review and critique. CNS Spectr. 2009 ; 14: 32-43
13. Davidson JR, Rothbaum BO, Van der Kolk BA, et al. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 2001 ; 58: 485-492
14. Dumont GJ, Sweep FC, Van der Steen R, et al. Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration. Soc Neurosci. 2009 ; 4: 359-366
15. Ehlers A, Steil R, Winter H, et al Deutsche Uebersetzung der Posttraumatischen Stress Diagnostic Scale (PDS). Oxford: Department of Psychiatry, Warnford Hospital, Oxford University ; 1996 :
16. Farre M, Abanades S, Roset PN, et al. Pharmacological interaction between 3,4-methylenedioxymethamphetamine (ecstasy) and paroxetine: Pharmacological effects and pharmacokinetics. J Pharmacol Exp Ther. 2007 ; 323: 954-962
17. Foa EB, Riggs DS, Dancu CV, et al. Reliability and validity of a brief instrument for assessing post-traumatic stress disorder. J Traum Stress. 1993 ; 6: 459-473
18. Foa EB, Cashman L, Jaycox L, et al. The validation of a self-report measure of posttraumatic stress disorder: The Posttraumatic Diagnostic Scale. Psychol Ass. 1997 ; 9: 445-451
19. Foa EB, Keane TM, Friedman MJ, et al Effective Treatments for PTSD, Practice Guidelines From the International Society for Traumatic Stress Studies. New York: Guilford Press ; 2009 :
20. Frewen PA, Lanius RA. Toward a psychobiology of posttraumatic self-dysregulation. Ann NY Acad Sci. 2006 ; 1071: 110-124
21. Greer GR, Tolbert R. A method of conducting therapeutic sessions with MDMA. J Psychoactive Drugs. 1998 ; 30: 371-379
22. Grob CS, Poland RE, Chang L, et al. Psychobiologic effects of 3,4-methylenedioxymethamphetamine in humans: Methodological considerations and preliminary observations. Behav Brain Res. 1996 ; 73: 103-107
23. Harris DS, Baggott M, Mendelson J, et al. Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacol. 2002 ; 162: 396-405
24. Hepp U, Gamma A, Milos G, et al. Prevalence of exposure to potentially traumatic events and PTSD in Switzerland. Eur Arch Psychiatry Clin Neurosci. 2006 ; 256: 151-158
25. Hoge CW, Castro CA, Messer SC, et al. Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care. N Engl J Med. 2004 ; 351: 13-22
26. Hysek CM, Simmler LD, Ineichen M, et al. The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA ("Ecstasy") in humans. Clin Pharmacol Therapeut. 2011 ; 90: 246-255
27. Jacobsen LK, Southwick SM, Kosten TR. Substance abuse disorder in patients with posttraumatic stress disorder: A review of the literature. Am J Psychiatry. 2001 ; 158: 1184-1190
28. Johansen PØ, Krebs TS. How could MDMA (ecstasy) help anxiety disorders? A neurobiological rationale. J Psychopharmacol. 2009 ; 23: 389-391
29. Kessler RC, Sonnega A, Bromet EJ, et al. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry. 1995 ; 52: 1048-1060
30. LandoltMASchnyderUMaierT. (2012) Trauma Exposure and Posttraumatic Stress Disorder: A national survey in Switzerland. Under review.
31. Liechti ME, Gamma A, Vollenweider FX. Gender differences in the subjective effects of MDMA. Psychopharmacol. 2001 ; 154: 161-168
32. Marshall RD, Beebe KL, Oldham M, et al. Efficacy and safety of paroxetine treatment for chronic PTSD: A fixed-dose, placebo-controlled study. Am J Psychiatry. 2001 ; 158: 1982-1988
33. McFarlane AC. The long-term costs of traumatic stress: Intertwinded physical and psychological consequences. World Psychiatry. 2010 ; 9: 3-10
34. Metzner R, Adamson S Ecstasy: The complete guide. Holland J, ed. Rochester, VT: Inner Traditions ; 2001: 182-207.
35. Mithoefer MC, Wagner MT, Mithoefer AT, et al. The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: The first randomized controlled pilot study. J Psychopharmacol. 2011 ; 25: 439-452
36. MithoeferMC (2011) MDMA-Assisted Psychotherapy for the Treatment of Posttraumatic Stress Disorder: A Revised Teaching Manual Available at: http://www.maps.org/research/mdma/Manual-MDMAPTSD-30Nov11.pdf (accessed 26 April 2012)
37. Mithoefer MC, Wagner MT, Mithoefer AT, et al. Durability of improvement in PTSD symptoms and absence of harmful effects or drug dependency after MDMA-assisted psychotherapy: A prospective long-term follow-up study. J Psychopharmacol. 2012 ;:
38. Ogden P, Pain C, Fisher J. A sensorimotor approach to the treatment of trauma and dissociation. Psychiatr Clin North Am. 2006 ; 29: 263-279
39. Panagioti M, Gooding PA, Tarrier N. A meta-analysis of the association between posttraumatic stress disorder and suicidality: The role of comorbid depression. Compr Psychiatry. 2012 ; 53: 915-930
40. Passie T, Dürst T Heilungsprozesse in Veränderten Bewusstsein. Berlin: Verlag für Wissenschaft und Bildung ; 2009 :
41. Perkonigg A, Kessler RC, Strorz S, et al. Traumatic events and post-traumatic stress disorder in the community: Prevalence, risk factors and comorbidity. Acta Psychiatr Scand. 2000 ; 101: 56-59
42. Rauch SL, Shin LM, Phelps EA. Neurocircuitry models of posttraumatic stress disorder and extinction: Human neuroimaging research-past, present, and future. Biol Psychiatry. 2006 ; 60: 376-382
43. Schnyder U. Why new psychotherapies for postraumatic stress disorder?. Psychother Psychosom. 2005 ; 74: 199-201
44. Schnyder U, Moergeli H. German version of clinician-administered PTSD scale. J Trauma Stress. 2002 ; 15: 487-492
45. Schnurr PP. The rocks and hard places in psychotherapy outcome research. J Trauma Stress. 2007 ; 20: 779-792
46. Spitzer M Musik im Kopf. Stuttgart: Schattauer Verlag ; 2002 :
47. Stein DJ, Ipser J, McAnda N. Pharmacotherapy of posttraumatic stress disorder: A review of meta-analyses and treatment guidelines. CNS Spectr. 2009 ; 14: 25-31
48. Tucker P, Zaninelli R, Yehuda R, et al. Paroxetine in the treatment of chronic posttraumatic stress disorder: Results of a placebo-controlled, flexible-dosage trial. Clin Psychiatry. 2001 ; 62: 860-868
49. Van Etten ML, Taylor S. Comparative efficacy of treatments for posttraumatic stress disorder: A meta-analysis. Clin Psychol Psychother. 1998 ; 5: 126-144
50. Vollenweider FX, Gamma A, Liechti M, et al. Psychological and cardiovascular effects and short-term sequelae of MDMA ("ecstasy") in MDMA-naive healthy volunteers. Neuropsychopharmacol. 1998 ; 19: 241-251
51. Weathers FW, Keane TM, Davidson MD. Clinician-administered PTSD scale: A review of the first ten years of research. Depress Anxiety. 2001 ; 13: 132-156
52. Widmer S Listening into the Heart of Things: The Awakening of Love: On MDMA and LSD: The Undesired Psychotherapy. Gerolfingen, Switzerland: Basic Editions ; 1998 :
53. Wolff K, Tsapakis EM, Winstock AR, et al. Vasopressin and oxytocin secretion in response to the consumption of ecstasy in a clubbing population. J Psychopharmacol. 2006 ; 20: 400-410